ReviewOncology reviews2025

Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action.

Nayoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.